Healthcare is booming, and these three companies stand to profit handsomely from growing demand for medications and surgeries ...
Khalil Asmar, VP of cardiometabolic health at Lilly UK & Ireland (l), and former England spin bowler Ashley Giles (r). Like ...
At ECO 2026, data from the SURMOUNT-MAINTAIN trial evaluating the use of Eli Lilly's Zepbound (tirzepatide) in sustaining weight loss was presented.
Alphabet-backed Isomorphic Labs has raised $2.1 billion to expand its AI drug discovery platform and advance medicines into ...
On CNBC's “Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, named Dominion ...
Dagens.com on MSN
Experts have studied Eli Lily’s Foundayo: Is it better than Ozempic?
Needles have become almost unavoidable in the booming world of weight-loss medicine. Weekly injections, strict schedules and ...
Orforglipron offers an "effective approach" for sustaining weight loss, especially for those not wishing to remain on jabs, a ...
The S&P 500, which is a leading benchmark of the US stock market performance, has surged by around 8.7% since the beginning ...
Biogen Inc. said it will continue development of its experimental Alzheimer’s drug after getting promising though not ...
Eli Lilly (NYSE:LLY | LLY Price Prediction) just delivered one of the most impressive quarters in big pharma history, and the ...
Eli Lilly has made a six-year, $50 million commitment to UNICEF USA to support efforts to improve the prevention, detection ...
The Investment Committee gives you their top stocks to watch for the second half.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results